USER GUIDE Score-TB package Find-TB...checklist (TB Harmonized Checklist) based on SLIPTA, but...

Preview:

Citation preview

1

Tuberculosis Technical Scorecard Building Quality-Assured Tuberculosis Testing and Management Capacity Utilizing SLIPTA Methodology Version 1.5 – July 2020

USER GUIDEScore-TB packageBuilding Quality-Assured Tuberculosis Testing and Management Capacity Utilizing SLIPTA MethodologyVersion 1.5 – July 2020

2

ContentsContents 2

Acronyms & Abbreviations 3

Acknowledgements 4

1. Guidance to readers 4

Background 4

Target audience 5

2. Overview 6

3. User Guide 7

3.1Requiredassessorcompetencyprofile 7

3.2Schedulingandperformingassessments 7

3.3TheSLIPTAchecklist(Version2:2015) 9

3.4TheTBLabQualityScorecards 9

3.4.1Useofthescorecards 9

3.4.2Scoring 10

3.4.3InformationonthespecificTBLabQualityScorecards 10

3.5 Reporting the assessment 31

References 32

3

Tuberculosis Technical Scorecard Building Quality-Assured Tuberculosis Testing and Management Capacity Utilizing SLIPTA Methodology Version 1.5 – July 2020

Acronyms & AbbreviationsASLM

BSC

BSL

CDC

DST

EQA

FIND

GLI

GLI tool

ICMR

ISO

LF-LAM

LJ

LMIC

LPA

LQSI tool

MTB

NA

NTM

NTP

NTRL

PT

QMS

RIF

RCF

SR

PPE

QC

SLIPTA

SLMTA

SOP

TAT

TB

TB SLMTA

TB-LAMP

USAID

WHOZN

AfricanSocietyforLaboratoryMedicine

BiologicalSafetyCabinet

BiosafetyLevel

UnitedStatesCentersforDiseaseControlandPrevention

DrugSusceptibilityTesting

ExternalQualityAssessment

FoundationforInnovativeNewDiagnostics

GlobalLaboratoryInitiative

GlobalLaboratoryInitiativeStepwiseProcessTowardsTBLaboratoryAccreditation

IndiaCouncilforMedicalResearch

InternationalOrganizationforStandardization

LateralFlowUrineLipoarabinomannanAssay

Löwenstein-Jensen

Low-andMiddle-IncomeCountries

Line-probeAssay

LaboratoryQualityStepwiseImplementationtool

Mycobacteriumtuberculosis

NotApplicable

NontuberculousMycobacteria

NationalTuberculosisProgram

NationalTuberculosisReferenceLaboratory

ProficiencyTesting

QualityManagementSystem

Rifampicin

RelativeCentrifugalForce

Substrate Reagent

PersonalProtectiveEquipment

QualityControl

StepwiseLaboratory(Quality)ImprovementProcessTowardsAccreditation

StrengtheningLaboratoryManagementTowardsAccreditation

StandardOperatingProcedure

Turnaround Time

Tuberculosis

SLMTAadaptedforTBlaboratories

TBLoop-MediatedIsothermalAmplification

UnitedStatesAgencyforInternationalDevelopment

WorldHealthOrganization

Ziehl-Neelsen

4

Tuberculosis Technical Scorecard Building Quality-Assured Tuberculosis Testing and Management Capacity Utilizing SLIPTA Methodology Version 1.5 – July 2020

AcknowledgementsThedevelopmentoftheScore-TBPackagewasledbyFINDwithcontributionsfromAndreTrollipandHeidiAlbert(FIND)andTjeerdDatemaandLindaOskam(DATOS).TheTBLabQualityScorecardsdrawfromanumberofexistingtools,includingCDCLaboratoryAssessmentofAntimicrobialResistanceTestingCapacitychecklist,IndiaCouncilforMedicalResearch(ICMR)TBChecklist,the World Health Organization (WHO) Regional Office for Africa's SLIPTAchecklistandFIND’sTBLaboratoryQualityManagementSystemsTowardsAccreditationHarmonizedChecklist.

1. Guidance to readersThisuserguideinstructsassessorsonhowtousetheScore-TBPackagefortuberculosis(TB)laboratoryassessment.Chapter2startswithanexplanationofthestructureandcontentsoftheScore-TBPackage.Chapter3proceedswithabriefexplanationofhowtoscheduleandperformassessmentsandhowtousetheindividualTBLabQualityScorecardsoftheScore-TBPackage.Thechapterendswithinstructionsonhowtoreportassessmentfindings.

Important:WeassumethatassessorsarelaboratoryexpertswithexperienceinTBtestingandinLaboratoryQualityManagement.Therefore,thisuserguidedoesnotprovidedetailedinformationonspecificTBtests.Instead,foreachTBtest,chapter3providesreferencestoguidanceandreferencematerialsdevelopedbypartners(includingtheGlobalLaboratoryInitiative(GLI),WorldHealthOrganization(WHO),andtheUnitedStatesAgencyforInternationalDevelopment(USAID)ChallengeTBproject)thatprovideessentialbackgroundinformationforassessors.Specifictechnicalinformationisalsoprovidedinthescorecardsthemselves.ItisassumedthatassessorsusingtheScore-TBPackagearealreadycertifiedandcompetentinconductinglaboratoryassessmentsandthattheycomplywiththerequiredassessorcompetencyprofiledescribedinsection3.1.

Background

Despitethefactthatlaboratoryresultsinfluence70%ofmedicaldiagnoses,laboratoryservicesinlow-andmiddle-incomecountries(LMICs)havelongbeenaneglectedcomponentofhealthcaresystems[1–7].TBlaboratories,whichareanessentialcomponentinallstagesoftheTBcarecascade,arenoexception[8].Akeyinterventiontostrengthenlaboratoryservicesistheimplementationofaqualitymanagementsystem(QMS)[9–11].AQMSisdefinedbytheInternationalOrganizationforStandardization(ISO)asthe“managementsystemtodirectandcontrolanorganizationwithregardtoquality”[12,13].Henceitisthesystem(“thesetofinterrelatedorinteractingelements”[13])aimedatimplementingandoperationalizingqualitymanagementinanorganization.StandardizationoftestingthroughimplementationofaQMShasbeenshowntoimprovethequalityoftestingbyreducingtestingerrors[14].

Severaltoolsandinitiativestoassistlaboratoriesimplementqualityimprovementactivitieshavebeendeveloped.OneofthemostsuccessfulapproachestoQMSimprovementistheStrengtheningLaboratoryManagementtowardAccreditation(SLMTA)approach,firstdescribedbyYaoetal.[15].TheSLMTAapproachisoftenusedinconjunctionwiththeStepwiseLaboratoryImprovementProcessTowardsAccreditation(SLIPTA)checklist[16].TheSLIPTAchecklistwasdevelopedbythe WHORegionalOfficeforAfricaandpartnersin2010inrecognitionofthegapbetweenthecurrentstateoflaboratoryqualityandtherequirementsoftheISO15189:2007standard[17].In2015,theSLIPTAchecklistwasadaptedtoincorporatetherequirementsoftheISO15189:2012standardandbecameknownas‘SLIPTAv2:2015’[18].

5

Tuberculosis Technical Scorecard Building Quality-Assured Tuberculosis Testing and Management Capacity Utilizing SLIPTA Methodology Version 1.5 – July 2020

TheFoundationforInnovativeNewDiagnostics(FIND)hasreportedonthedevelopmentofaTBlaboratory-specificapproachcalledTBStrengtheningLaboratoryManagementtowardAccreditation(TBSLMTA)[19].TheprogramisbasedontheexistingsuccessfulSLMTAapproachandutilizedarevisedchecklist(TBHarmonizedChecklist)basedonSLIPTA,butincorporatingsomeelementsfromtheGLItoolwithafocusonthetechnicalsideofTBlaboratorytesting.

In2019,anadditionaltechnicalrevisionwasmadetotheTBSLMTAHarmonizedChecklisttoincludeTBtestingmethodsnotincludedinpreviousrevisions.ThecurrentmajorrevisionconcernstheincorporationoftheTBSLMTAHarmonizedChecklistintothe‘Score-TBPackage’,whichalsoincludesanelectronicversionofthechecklistreferredtoasthe‘e-tool’.Thee-toolsubstantiallyincreasesuser-friendlinessandreducestheriskforerrorsbyautomatingthecalculationofassessmentscoresandpresentingtheseinareportingworksheettovisualizestrengthsandweaknessesofalaboratory’sQMS(theSLIPTAscore)andTB testing methods.

Target audience

TheScore-TBPackageisintendedtoinformMinistriesofHealthofficials,healthfacility-andlaboratorymanagers,donors,implementingpartners,qualityassurancepersonnel,programmanagersandsupervisorystaffatnational,regionalandfacilitylevelonrequirementsfordeliveringquality-assuredlaboratorytestingforTBandensuringeffectiveuseoflaboratoryresourcesaswellasdataforpatientmanagementandsurveillanceinLMIC.

6

2. OverviewTheScore-TBPackageconsistsofthefollowingcomponents:

1. The User Guide2.TheTBLabQualityScorecards,consistingofthefollowingscorecards:

1. Generalprocedures ThisscorecardincludesquestionsthatarenotrelatedtoonespecificTBtestbutarerelevantforaTBlaboratory.Thisscorecardshouldalwaysbecompletedforeachassessment.

2. Smear microscopy Containsquestionspecificforsmearmicroscopy(lightmicroscopyand/orfluorescencemicroscopy),onlyapplicabletolaboratoriesthatperformthistest.

3. TBculturefordetectionandidentificationofmycobacteria ContainsquestionsspecificforTBculture,onlyapplicabletolaboratoriesthatperformthistest.

4. PhenotypicDrugSusceptibilityTesting(DST) ContainsquestionsspecificforDST,onlyapplicabletolaboratoriesthatperformthistest.

5. XpertMTB/RIF ContainsquestionsspecificforXpertMTB/RIFandXpertMTB/RIFUltratesting,onlyapplicabletolaboratoriesthatperformthistest.

6. LateralFlowUrineLipoarabinomannanAssay(LF-LAM) ContainsquestionsspecificfortheLF-LAMtest,onlyapplicabletolaboratoriesthatperform this test.

7. Loop-MediatedIsothermalAmplification(TB-LAMP) ContainsquestionsspecificfortheTB-LAMPtest,onlyapplicabletolaboratoriesthatperform this test.

8. LineProbeAssay(LPA) ContainsquestionsspecificforLPA,onlyapplicabletolaboratoriesthatperformthistest.

9. TrueNat ContainsquestionsspecificfortheTruenattest,onlyapplicabletolaboratoriesthatperform this test.

3. The SLIPTA checklist

InthehardcopyversionoftheTBscorecards,referencestoSLIPTAchecklistquestionsaregiven.Inthee-tool,theTBscorecardquestionsareincorporatedintheSLIPTAchecklist,meaningthatthescoresontheTBscorecardquestionsareincorporatedinthecalculationoftheSLIPTAscore.

Additional resources:

1.WHOSLIPTAChecklistVersion2:2015

7

Tuberculosis Technical Scorecard Building Quality-Assured Tuberculosis Testing and Management Capacity Utilizing SLIPTA Methodology Version 1.5 – July 2020

3. User Guide ThischapterexplainshowtoscheduleandperformassessmentsusingtheScore-TBPackageandhowtousetheTBLabQualityScorecards,andhowtocalculateandreportassessmentfindings.Inaddition,referencestoessentialguidanceandreferencematerialsdevelopedbypartnersareprovidedforeach scorecard. 3.1 Required assessor competency profile

Assessmentsareobjectivemeasurestoinvestigatecompliancewithstandardsand/orregulations.AssessmentsconductedusingtheScore-TBPackageshouldyielddetailedinformationonaTBlaboratory’squalityingeneral,andthecorrectconductofspecificTBdiagnostictests.Itisthereforeessentialthatassessorsarecompetentandfamiliarwithallthedetailsof,andrecommendationsrelatedto,theTBtestshe/sheisgoingtoassess.Therefore,theassessmentsusingtheScore-TBpackageshouldonly be conducted by SLIPTA certified assessorswho,inaddition,are:

• FamiliarwithTBlaboratorypractice• Wellversedin,andknowledgeableof,thedetailsrelatedtothespecificTBtestsincludedinthe Score-TBPackage.

3.2 Scheduling and performing assessments

Assessmentsareaneffectivemeansto:1)determineiftheTBlaboratoryisprovidingaccurateandreliableresultsforTB;2)determineiftheTBlaboratoryandclinicalsitesarewell-managedandlaboratoryresultsarebeingreportedandusedeffectivelyforclinicalmanagementandsurveillance;and3)identifyareasforimprovement. Thescorecardscanbeusedinseveralways:

1. FortheassessmentofaTBlaboratory,theTBLabQualityScorecardscanbeusedwithorwithouttheSLIPTAchecklistaswillbefurtherexplainedbelow.

2. Assessorsmayelecttoconducttheassessmentusingpaper-basedscorecardswithlaterentryofdataintothee-toolforscorecalculation,analysis,andreporting,ortheymayenterdatadirectlyintothee-toolatthetimeoftheassessment1.Itisstronglyrecommendedtousethee-toolforscorecalculation(seebelow).

3. AssessorsmayelecttoperformtheSLIPTAassessmentfirstandthentheTBassessment,orviceversa.4. Itisrecommendedthataminimumoftwoassessorsperformtheassessment,wherebyoneasksthequestionsandthesecondpersonrecordstheanswers.

5. Theassessorsshouldallowapproximately6hourstocompletetheGeneralProcedures-scorecardandapproximately1-2hourstocompleteeachtestspecificscorecard.

6. Theassessorshouldallowapproximately1.5daystocompletetheSLIPTAchecklist.7. Assessorsshoulddiscussaccessingdatawiththelaboratorypriortoperformingtheassessment.Laboratoriesshouldalsoberequestedtoprovidekeyqualitydocuments(suchasSOPs,qualitymanual,biosafetymanual,etc.)andquantitativedatainadvanceoftheassessmentforreviewbytheleadassessor.Ifthelaboratoryisunabletoprovidedocumentationanddatainadvance,assessorsshouldscheduleadditionaltimetoreviewdocumentationon-site.Alternatively,anadditionalassessorcanbetaskedwithdocumentreview,whiletheotherassessor(s)assessthetechnicalaspectsofthelaboratory.

8. Laboratoriesshouldberequestedtoprovidekeyqualityindicatordata(seesection11ofeachscorecard).

1Fullinstructionsonuseofthee-toolareprovidedwithinthee-toolitself.Informationanddatacollectedinthepaper-basedscorecardsande-toolarethesame.

8

9. Assessorsshouldnotethatwhenplanningassessmentsofmultiplelaboratories,thelengthofthevisitswillvarybaseduponfourmainfactors:

I. Numberoflaboratoriestobeassessed.II. Sizeofthelaboratoriestobeassessed.III. Testmenu/diagnosticspectrumofthelaboratoriestobeassessed.IV.Numberofassessorsontheassessmentteam.V. Logistics and transportation considerations.

Duringtheassessment,assessorsshould: • Explainatthestartoftheassessmentthescopeoftheassessment,theassessmentmethod,andensurethatstaffarecomfortabletocontributetotheassessmentbymakingthemunderstandthatthisisnotapersonalcompetencyassessmentbut,instead,anassessmentofthelaboratoryprocesses,andthattheassessmentisnotintendedtoleadtodisciplinarymeasuresagainstindividualsbuttoimprovethefunctioningofthelaboratoryasawhole.

• Aggregatedataand/orreviewexistingqualityindicatordatatodeterminethenumberoftestsbymethodtype,aswellasthenumberofpositiveresults,DSToutcomesandnumberofnegativeorcontaminatedcultures(whereapplicable).

• Reviewlaboratoryanddocumentstotriangulatefindingsandverifythatpolicies,manuals,StandardOperatingProcedures(SOPs)andotherdocumentationarecomplete,current,accurate,and annuallyreviewed.

• ReviewrecordsandotherrelevantdocumentstoverifythatTBpoliciesarebeingfollowed.• Observelaboratoryoperationstoensure:

− aboratorytestingfollowswrittenpoliciesandproceduresinpre-analytic,analyticandpost-analyticphasesoflaboratorytestingforTB.

− laboratoryproceduresareappropriateforthetestingperformed. − deficienciesandnon-conformitiesidentifiedareadequatelyinvestigatedandresolvedwithintheestablishedtimeframe.

• Askopen-endedquestionstoclarifydocumentationseenandobservationsmade.Askquestionslike,“showmehow…”or“tellmeabout…”Itisoftennotnecessarytoaskallthechecklistquestionsverbatim.Anexperiencedassessorcanoftenanswermultiplechecklistquestionsatthesametimethroughopen-endedquestions.

• Followapatientspecimenthroughthelaboratoryfromcollectionthroughregistration,preparation,analyzing,resultverification,reporting,printing,andpost-analytichandlingandstoringsamplestodeterminethestrengthoflaboratorysystemsandoperations.

• Checkwhetherproficiencytesting(PT)resultsarereviewedandcorrectiveactiontakenasrequired.• Evaluatethequalityandefficiencyofsupportingworkareas(e.g.,samplecollection,dataregistrationandreception)andstaff(messengers,drivers,cleanersandIT)andoversightcommitteessuchastheHospitalmanagementandtheNationalTBProgram.

• Modelpropersafetypracticesandtakenecessarysafetyprecautionsduringtheassessment.E.g.:weartheproperPersonalProtectiveEquipment(PPE)(gown,gloves,mask).

9

Tuberculosis Technical Scorecard Building Quality-Assured Tuberculosis Testing and Management Capacity Utilizing SLIPTA Methodology Version 1.5 – July 2020

3.3 The SLIPTA checklist (Version 2:2015)

TheTBLabQualityScorecardsaredesignedtobeusedinconjunctionwiththeSLIPTAchecklist(Version2:2015).TheSLIPTAchecklistwasdevelopedbyWHO Regional Office for Africa,incollaborationwiththeAfricanSocietyforLaboratoryMedicine(ASLM),U.S.CentersforDiseaseControlandPrevention(CDC)andhostcountries.Theobjectiveofthechecklististoprovideaframeworkforimprovingqualityof(public)healthlaboratoriesindevelopingcountriestoachievetherequirementsoftheISO15189standard.Sinceitsinceptionin2008,theSLIPTAchecklisthasundergoneonerevisionin2015.ThecurrentSLIPTAchecklist(v2)canbedownloadedfromhttp://apps.who.int/iris/handle/10665/204423.

ItisbeyondthescopeofthisuserguidetoprovideinstructionsontheuseoftheSLIPTAchecklist.TheSLIPTAchecklistitselfcontainsinstructionsforitsuse(seePartIIoftheSLIPTAchecklist)andfurtherinstructionsareprovidedintheSLIPTAGuidewhichcanbedownloadedathttp://www.who.int/tb/laboratory/afro-slipta-checklist-guidance.pdf.ComprehensivetrainingforSLIPTAauditorsisprovidedbyASLM(http://www.aslm.org/what-we-do/slipta/).

3.4 The TB Lab Quality Scorecards

TheTBLabQualityScorecardsareavailableinhard-copyandelectronic(e-tool)formats.Thee-toolalsocontainsadigitalversionoftheSLIPTAchecklist,wherebytheTBLabQualityScorecardsaremergedwiththeSLIPTAchecklisttoenablecalculationofone,overall,TB-SLIPTAscoreforthelaboratory.

3.4.1 Use of the scorecardsItisstronglyrecommendedtousethee-toolinsteadofthepaper-basedscorecardsforscorecalculationbecausethee-toolenablesautomaticcalculationofscoreswhereaswiththepaper-basedscorecardsthisneedstobedonemanually,whichismorepronetoerrors.Anotheradvantageofusingthee-toolisthatitdirectlyvisualizesthescoringandtheprogresssincethepreviousassessment,ifapplicable.Thepaper-basedscorecardscouldbeconvenientforuseduringtheassessmenttonotefindingsontheprintedscorecardswithtranscriptionintothee-tooldirectlyfollowingtheassessment.Notethat,ifobservingTBtestingintheBiosafetyLevel(BSL)3facility,paper-basedscorecardsshouldbeusedandtheuseofelectronicdevicesbeavoidedforsafetyreasons.

TheTBLabQualityScorecardscanbeusedintwowayswhenusingthee-tool:

1. OnecouldassessthecorrectimplementationandoperationofspecificTBtests,usingtheGeneralProcedures-scorecardincombinationwiththerespectivescorecardsforthetestsasstand-alonescorecards.Thee-toolwillcalculateascoreforthescorecardsthathavebeencompleted.

2. OnecouldusetheTBLabQualityScorecardsaspartofacomprehensiveSLIPTAassessmenttoverifycorrectimplementationofSLIPTArequirements,withaspecificfocusonTBtesting.Thee-toolwillcalculatescoresforeachscorecardbutwillalsocalculateone,overall,SLIPTAscore.

Inanassessment,theGeneralprocedures-scorecardshouldalwaysbeused.ThisscorecardcontainsquestionstoassessTB-specificlaboratoryprocessesunrelatedtospecificTBlaboratorytests.Subsequently,dependingonthetestmenuofthelaboratory,theassessor(s)mayuseoneormoretechnicalscorecardstoassesstechnicalcomplianceofspecificlaboratorytests.Forexample:

• Ifalaboratoryonlyperformssmearmicroscopy,thislaboratoryshouldbeassessedwiththeGeneralprocedures-scorecardandtheSmearmicroscopyscorecard.

• Ifalaboratoryperformssmearmicroscopy,culture,DSTandLF-LAM,thislaboratoryshouldbeassessedwiththeGeneralprocedures-scorecardandthescorecardsforsmearmicroscopy,culture,DSTandLF-LAM.

Inthee-tool,onthe‘SetAuditScope’-tab,theassessorcanindicatewhichtestsareperformed.Basedontheselection,thee-toolwillprovidealistoflinkstoscorecardsthatshouldbeusedfortheassessment.

10

3.4.2 ScoringTheTBLabQualityScorecardsusethesamescoringsystemastheSLIPTAchecklist.Eachscorecardquestionhasbeenawardedapointvalueof2,3,or5points—basedonrelativeimportanceand/orcomplexity.Responsestoallquestionsareratedas,“yes”,“partial”,or“no”.Questionsansweredwith“yes”receivethecorrespondingpointvalue(2,3,or5points).Forquestionswithsubquestionsor“ticklists”,allsubquestionsmustbeansweredwith“yes”toreceivethemaximumnumberofpoints. • Questionsmarked“partial”receive1point.• Questionsmarked“no”receive0points.• Whenmarking“partial”or“no”,notesshouldbewritteninthecommentsfieldtoexplainwhytherequirementwasnotfulfilled.

• Whenquestionconsistsofsubquestions,theoverallanswercanonlybe“yes”ifallsubquestionsareansweredwith“yes”.

Whereachecklistquestiondoesnotapply,thisshouldbeindicatedas“NA”.Inthiscase,thequestiondoesnotcountforthecalculationoftheoverallscore.Thee-toolautomaticallyomitsquestionsansweredwithNAfromthecalculationoftheoverallscore.Itisthereforerecommendedtousethee-tooltocalculatethescores.Ifthepaper-basedscorecardsareusedinsteadofthee-tool,theassessorshoulddothiscalculationmanually.Inthiscase,theassessorshouldcalculatethesumoftotalpossiblepointsthatcanbescoredwithallquestionsansweredwith“NA”andsubtractthatfromthetotalnumberofpointsthatcanbescoredfortheoverallsection.Thispreventsthatlaboratoriesforwhichcertainquestionsarenotapplicable,areneverabletoreachthemaximumscore.

Example: During an assessment, question 11.2 of the General Procedures-scorecard: “Are aggregate reports shared periodically with clinicians/NTP/NTRL (as applicable)?” is answered with ‘NA’. The total number of points that can be scored with this question is 2. The total number of points that can be scored in the General Procedures-scorecard is 72. But because this question is answered with ‘NA’, the two points for this question should be subtracted from the total number of points that can be scored in the General Procedures-scorecard, which, hence, becomes 70.

3.4.3 Information on the specific TB Lab Quality ScorecardsBelow,detailedguidanceisprovidedoncompletingeachTBLabQualityScorecard,startingwiththeGeneralProcedures-scorecard,followedbythetest-specificscorecards.Thescorecards(withorwithoutSLIPTA)canalsobeusedforinternalandexternalaudits.

Scorecard structure

Allscorecardshavethesamestructure,consistingofthreeparts:

• Score• PartA:Generalinformation• PartB:Technicalinformation

Scoresummarizesthescoresfortheassessment.This section should only be completed if the assessor uses the paper-based scorecards without the e-tool as the e-tool calculates the scores automatically.

11

Tuberculosis Technical Scorecard Building Quality-Assured Tuberculosis Testing and Management Capacity Utilizing SLIPTA Methodology Version 1.5 – July 2020

Ifcompletingthissection,assessorsshouldnotethedateofthecurrentassessmentandthedateofthepreviousassessment,ifany.Thetotalpointsscoredforeachscorecardsectionshouldbetranscribedtotheplaceprovidedandthepercentageforeachsectioncalculated(pointsofsectiondividedbytotalpointsexpressedasapercentage).Notethatsomequestionsmaynotbeapplicablewhichthenaffectstheoveralltotalofthechecklist–assessorsshouldreplacethedenominatorandcalculatescorebasedonthepercentageaccordingly,asexplainedinparagraph3.3.2.Onceallthesectionsarecompleted,thetotalscoreandtotalpercentagecanbecalculated.Starsaresubsequentlyawardedbasedonthefollowingthresholds:

• Nostars:<55%• 1star:55%-64%• 2stars:65%-74%• 3stars:75%-84%• 4stars:85%-94%• 5stars:≥95%

Ifapreviousassessmenthasbeenperformed,assessorsshouldreviewthescoresandnotewhetherthelaboratoryhasimprovedsincethelastassessment.Improvementsandprogress(orlackthereof)towardsmeetinglaboratoryassessmentobjectivesshouldbereviewedwithlaboratorymanagement(see3.4Reportingtheassessment).

Part A: General informationiscompulsoryforallassessments.ThesectionisusedtocollectgeneralinformationabouttheTBlaboratoryandprovidestheassessorthecontextforperformingtheassessment.ThissectionismostelaborateintheGeneralProcedures-scorecardwhereasitisonlyminorinthetest-specificscorecards.Thesectionisbestcompletedbythefacilitymanager(orequivalent)beforethestartoftheassessmentandverifiedatthestartoftheassessmentatthelaboratory.

Part B: Technical information, isthemostelaboratepartofthescorecards.Inallscorecards,PartBstartswithasectioncapturingquantitativedataonspecificaspects,suchasequipmentavailability,functioning,servicingandmaintenance,thenumberoftestsperformed,stratifiedinseveralcategories,thereportingmethodologyusedbythelaboratory,etc.Itisstronglyrecommendedtoaskthelaboratorytocompletethesectionitselfpriortotheassessment,afterwhichtheassessorsverifycorrectcompletionofthissectionatthestartoftheassessment.Thisisrecommendedbecausethecollectionofquantitativedatawillrequiretimethatmightnotbeavailableduringtheassessment.

TheremainderofPartBconsistsof‘closed’/multiple-choicequestions.Thesameoutlineisusedforallscorecards,followingtheSLIPTAchecklist.ThequestionsineachsectionsupplementthequestionsoftheSLIPTAchecklistandshouldbeaskedinconjunctionwiththequestionsfromtheSLIPTAchecklist.Thequestionscoverthefollowingtopics:

• Section1:Documents&Records Questionscoverdocumentationrelatedtopolicies,processes,clientinstructions,andrecordingandreportingmechanismsspecificforTBtesting.Documentscanberequestedandreviewedpriortotheassessment.TheanswersarebestverifiedtogetherwiththeLaboratoryManagerand/orthepersonresponsibleforthedocumentcontrolsystem.QuestionsrelatedtoSection2arepresentin allscorecards.

12

• Section2:ManagementReviews QuestionscoverthereportingoflaboratoryfindingsandqualityindicatorsatanaggregatedleveltodecisionmakerssuchasNTPandNTRL.Documentssuchasyearlyreportscanberequestedandreviewedpriortotheassessment.TheanswersarebestverifiedtogetherwiththeLaboratoryManager.QuestionsrelatedtoSection2areonlypresentintheGeneralProcedures-scorecard.

• Section3:Organization&Personnel QuestionscovertrainingofstaffandstafffollowingproceduresasdescribedintherelevantSOPs.Trainingrecords,competencyassessmentreportsanddutyrosterscanberequestedandreviewedbeforehandandverifiedwiththeLaboratoryManagerand/orHRManager.WhetherstafffollowsproceduresshouldbeobservedatthebenchanddirectlyobservedwiththeSOP.Randomlychoosea fewtechniquestoobserve.QuestionsrelatedtoSection3areonlypresentintheGeneral Procedures-scorecard.

• Section4:ClientManagement&CustomerService Questionscoverinstructionsforsamplecollectionofsputumsamplesaswellasextra-pulmonarysamplesandfeedbacktocliniciansaftertesting.InstructiondocumentssuchastheCustomerHandbookcanberequestedandreviewedbeforehand,feedbacktoclinicianscanbediscussedwiththeLaboratoryManagerormicrobiologist/pathologistandproofshouldberequested.Questionsrelatedtosection4arepresentinallscorecards.

• Section5:Equipment Equipmentquestionscovertheuseofverifiedandvalidatedmethods2,installation,location,andmaintenanceofequipment.ThesecanbebestdiscussedwiththeEquipmentOfficer(technicalaspects)andtheQualityOfficer(verificationandvalidationaspects).Randomlychooseafewtechniquestoobserve.QuestionsrelatedtoSection5areonlypresentintheGeneralProcedures-scorecard.

• Section6:EvaluationandAudits QuestionscoverregularinternalandexternalauditingoftheTBlaboratory(separatelyoraspartoflargeraudits)andfollowupofresultingrecommendationsandactionplans.ThesecanbebestdiscussedwiththeQualityOfficer.Documentationforfollowupofactionsshouldbereviewed.QuestionsrelatedtoSection6areonlypresentintheGeneralProcedures-scorecard.

• Section7:Purchasing&Inventory Questionsarerelatedtotheuseofcorrectspecificationsandthecorrectstorageofreagentsandsupplies.ThesecanbebestdiscussedwiththeStockOfficer.Visitthestorageareaandobserveafewreagentsandsuppliescriticaltocorrectperformance.Checkstorageconditionsandexpirationdates.QuestionsrelatedtoSection7arepresentinallscorecards.

2Themainobjectiveofvalidationandverificationistodemonstratethatanexaminationprocedureisfit-for-purpose(JLabPrecisMed2017;2:58).Useofnon-validated/non-verifiedexaminationproceduresarenotuncommoninthelaboratory.Whenusedwithoutmodification,avalidatedexaminationprocedureshallbe**verified**,whilstnon-standardmethods,homebrewmethods,validatedmethodswhichhavebeenmodifiedorarebeingusedoutsidetheirintendedscopeshallbe**validated**.

13

Tuberculosis Technical Scorecard Building Quality-Assured Tuberculosis Testing and Management Capacity Utilizing SLIPTA Methodology Version 1.5 – July 2020

• Section8:ProcessControl Processcontrolisthemostextensivesectioninallscorecards.Questionsarerelatedtothecorrectperformanceofthetestingprocedure,qualitycontrol,qualityassuranceandexternalquality3. DocumentsrelatedtoEQAscorescanberequestedandreviewedbeforehandanddiscussedwiththeLaboratoryManagerand/orQualityOfficer.Executionoftestsincludingqualitycontrolsshouldbeobservedatthebenchandintheresultsrecordingledger.

• Section9:InformationManagement Questionscovertherecordingandreportingofindividualtestresults.Thesecanbebestdiscussedandverifiedwiththepersonresponsibleforreportsubmission.Thecorrectregistrationofresultscanbebestcheckedforcomplextestresult(forexampleDSTorLPA)astranscriptionerrorsmaybemostprevalent.QuestionsrelatedtoSection9areonlypresentintheGeneralProcedures-scorecard.

• Section10:IdentificationofNonconformities,CorrectiveandPreventiveActions Questionsarerelatedtotheidentificationanddocumentationofnon-conformities,theiranalysis10 andcorrectiveactions.ThesequestionscanbebestdiscussedwiththeQualityOfficer.Documentsdescribingnon-conformities,theiranalysisandcorrectionshouldbereviewed.QuestionsrelatedtoSection10areonlypresentintheGeneralProcedures-scorecard.

• Section11:Occurrence/IncidentManagement&ProcessImprovement Questionsarerelatedtothecollectionandreportingofperformanceindicators.DocumentscanberequestedandreviewedbeforehandandarebestdiscussedandverifiedwiththeLaboratoryManagerand/orpersonresponsiblefordatamanagement.QuestionsrelatedtoSection11arepresentin allscorecards.

• Section12:FacilitiesandBiosafety Questionscoverthesafeperformanceoftestingandwastemanagement.ThesecanbebestdiscussedwiththeSafetyOfficerandobservedatthebench.QuestionsrelatedtoSection10areonlypresentintheGeneralProcedures-scorecard.

Notallscorecardscontainquestionsforeachsection.Forexample:Section2:ManagementReviews,onlycontainsquestionsintheGeneralProcedures-scorecard.Inthetest-specificscorecardstherearenoquestionsrelatedtomanagementreviews.

3QualityControl:theactivitiesundertakenduringthetestingproceduretoensurethatresultsarereliable(ingeneral:positiveandnegativecontrols).QualityAssurance:theactivitiesundertakenbeforetestingtoensurethatresultsarereliable(suchastrainedstaff,highqualitymaterialsandequipment,presenceofdocumentssuchasSOPs).ExternalQualityAssessment:proficiencytesting,blindedretestingand/orinspectionvisitsbyanexternalentitytoassessthereliabilityoflaboratorytestresults.4RootCauseAnalysisaimsatidentifyingtheunderlyingproblemcausingthenon-conformity.EstablishedtechniquesaretheIshikawaDiagram(https://en.wikipedia.org/wiki/Ishikawa_diagram)andtheFiveTimesWhymethod(https://en.wikipedia.org/wiki/Five_whys).

14

Information on completing the General Procedures-scorecard

PartA:GeneralInformation

ThissectionismoreelaborateintheGeneralProcedures-scorecardcomparedtootherscorecards.Asexplainedabove,thissectioncapturestheinformationtoprovidethecontextagainstwhichtheassessmentisconducted.Theassessorwillfillhis/hernameandaffiliationsandthenameanddetailsofthelaboratorybeingassessed.Toanswerthequestion“DoestheTBlaboratorymeetminimumspaceandinfrastructurerequirements?”,theassessormayrefertotheGLIMycobacteriologyLaboratoryManual,chapter4,section4.15.

PartB:Technicalinformation

IntheGeneralProcedures-scorecardtwoquestionshavebeenincludedthatcapturequantitative/descriptivedata:

• QuestionGAisintendedtogetanoverviewoftheavailableequipmentandthestateofmaintenance/calibration.Assessorsshouldnotewhethertheequipmentisinworkingorder,thefunctionalityofequipmentregularlychecked;theequipmentregularlyservicedbyaqualifiedservicetechnicianandwhethertheequipmentisregularlymaintainedaccordingtothemanufacturer’srecommendations.Ifmolecularmethodsarebeingused,theassessorshouldreviewtheSOPtodeterminetherequirementsandlisttheseunder“otherequipment”.AssessorsmayneedtoreviewtheSOPorequipment“BookofLife”todeterminespecificsregardingmaintenance,servicingetc.forspecializedmolecularsystems.

• QuestionGBismeanttoprovideinsightintothereportingprocessforthedifferentlaboratorytests.

TheremainderofpartBintheGeneralProcedures-scorecardconsistsofclosed/multiplechoicequestions.IntheGeneralProcedures-scorecardthesequestionsarenotspecifictoanylaboratorytests.Instead,theyarerelatedtosupportprocessofthelaboratory.

IntheGeneralProcedures-scorecard,questionsareincludedinalltwelvesections.Mostquestionsareself-explicatory.However,ifadditionalinformationisneeded,thebelowresourcescanbeconsulted.

5GLIMycobacteriologyLaboratoryManual:http://www.stoptb.org/wg/gli/assets/documents/gli_mycobacteriology_lab_manual_web.pdf

15

Tuberculosis Technical Scorecard Building Quality-Assured Tuberculosis Testing and Management Capacity Utilizing SLIPTA Methodology Version 1.5 – July 2020

Resource Description

General information

GLIMycobacteriologyLaboratoryManual

Acomprehensivelaboratorymanualthatstandardizeskeylaboratoryprocedures.

GLIPracticalGuidetoTBLaboratory Strengthening

PracticalguidanceonimplementationofWHOrecommendationsandinternationalbestpracticesforTBlaboratorystrengthening.

GLIModelTBDiagnosticAlgorithms

Thishandbookprovides4modelalgorithmsthatgraphicallydepictthemostup-to-dateWHOrecommendationsonuseofTBdiagnostics.ThealgorithmsfollowtheprinciplesoftheEndTBStrategytoprovideuniversalaccesstorapidtestingforMycobacterium tuberculosiscomplexbacteriaandDST,andincludetheuseofXpertMTB/RIF,lineprobeassaysfor2ndlinedrugs,theLF-LAMassayandtheTB-LAMPtest,togetherwithconventionaltoolsincludingmicroscopyandphenotypiccultureandDST.

WHODefinitionsandreportingframeworkfortuberculosis

WHOstandardizeddefinitionsandreportingstructuresforTB.

General information

WHOLaboratoryQualityManagementSystemHandbook

HandbookforunderstandingthestructureandrequirementsofalaboratoryQMSbasedoninternationalstandards.

WHOLaboratoryQualityManagementSystemtrainingtoolkit

TrainingmaterialsforunderstandingthestructureandrequirementsofalaboratoryQMSbasedoninternationalstandards.

WHOLaboratoryQualityStepwiseImplementation(LQSI)tool

TheLQSItoolprovidesaroadmapforstepwiseimplementationofalaboratoryQMSbasedoninternationalstandardsfor(public)healthlaboratories.

ISO15189QualityManagementSystemImplementationLookBeforeYouLeap–BestPracticeGuidanceDocument

ThisguidancedocumentisdesignedtoprovidepublicTBlaboratorieswithbestpracticeswhenembarkingonimplementingaQMSandseekingISO15189accreditation.

GLIStepwiseProcessTowardsTB Laboratory Accreditation (‘GLItool’)

ThistoolprovidesaroadmapforstepwiseimplementationofalaboratoryQMSbasedoninternationalstandardsforTBlaboratories.

GLIStandardOperatingProceduresfortheTBLaboratory

TemplatesofSOPsfortheTBlaboratory.

Specimen referral and transport

GLI Guide to TB Specimen ReferralSystemsandIntegratedNetworks

Thisguidedescribesthevariousphasestocreateandstrengthenspecimenreferralsystems,essentialcomponentsinvolvedinreferral,aswellasotherconsiderationsforTBprogrammeandlaboratorymanagers,MinistryofHealthofficials,andotherstakeholdersacrossdiseaseprogrammes.Inadditiontodescribingtransportmechanismsandequipmentrequiredtomovespecimensinasafemanner,thisguidealsoprovidesinformationonlogistics,resultsreporting,datamanagement,monitoringandevaluation,andstandardoperatingproceduresthatwillfacilitateandimprovespecimenreferralsystems

16

Resource Description

Biosafety

GLILaboratorySafetyHandbook

TheLaboratorySafetyhandbookisapracticalguideforlaboratorystaff.TheHandbookusessimpletextandclearillustrationstoassistlaboratorystaffinunderstandingtheimportantsafetyissuesinvolvedinperformingcultureandDST.TheTBLaboratorySafetyhandbookshouldbeusedtogetherwiththeWHOTuberculosisLaboratoryBiosafetyManual.

WHOTBLaboratoryBiosafetyManual

ThismanualprovidesinformationandexplanationonbiosafetyrequirementsfortheTBlaboratorycontext.

WHOLaboratoryBiosafetyManual

Thismanualprovidesinformationandexplanationonbiosafetyrequirementsformedicallaboratories.

Other

TBfacts.org ThiswebsiteisausefulresourceprovidinginformationonTBingeneralandforTBlaboratorytestingspecifically.

GLIresourcecenters:• Guidanceandtools• Training packages• SOPs

ProvidesmanyadditionalresourcesforTBlaboratorypractice.

ChallengeTBtools,guidelinesandmanuals

ProvidesmanyadditionalresourcesforTBlaboratorypractice.

WHOpublicationsontuberculosis

ProvidesmanyadditionalresourcesrelatedtoTBdetection,diagnosis,treatment,and care.

17

Tuberculosis Technical Scorecard Building Quality-Assured Tuberculosis Testing and Management Capacity Utilizing SLIPTA Methodology Version 1.5 – July 2020

Information on completing the Smear Microscopy Scorecard

PartA:GeneralInformation

PartAoftheSmearMicroscopyScorecardislimitedtoaddingdetailsaboutthisassessment(incl.nameandaffiliationoftheassessorandthelaboratorybeingassessed,andinformationaboutthepreviousassessment,ifany).

PartB:Technicalinformation

PartBstartswithatabletocollectinformationonthenumberofsmearmicroscopytestsfordiagnosisandfollow-upperformedinthelastyear.Datashouldbestratifiedbythenumberofsamplesreceivedandrejected,andthenumberofscantypositive,positiveandnegativeresultsperquarter.Itisrecommendedtoaskthelaboratorytocompletethistableinadvanceandverifytheinformationduringtheassessment,astherewillnotbesufficienttimeavailableduringtheassessmentforcompletionofthistable.

• Section1:Documents&Records Containingquestionsaboutdocumentationofsmearmicroscopy-specificprocedures.

• Section4:ClientManagement&CustomerService Containingaquestionrelatedtoprovisionofinformationandinstructionstoclientsoninterpretationofsmearmicroscopyresults.AquestionfocusingoncorrectcollectionofsputumsamplesisincludedintheGeneralProcedures-scorecard.

• Section7:Purchasing&Inventory Containingaquestiononstorageofreagentsneededformicroscopy.

• Section8:ProcessControl Thissectionismostelaborateasitinvestigatestechnicaldetailsforcorrectexecutionofsmearmicroscopy(usefulresourcesareprovidedbelow).

• Section11: Containsaquestionrelatedtosmearmicroscopy-specificqualityindicators.

Mostquestionsareself-explicatoryandassessorscomplyingwiththeassessorprofiledescribedinsection3.4shouldbeabletoanswerthem.Below,severalusefulresourcesarelistedthatprovideessential(technical)informationaboutthesmearmicroscopyprocedure.

18

Resource Description

Smear microscopy procedure

MovieonAuraminestaining DemonstrationofAuraminestaining.

MovieonZiehlNeelsenstaining

DemonstrationofZiehl-Neelsenstaining.

Handbook:LaboratoryDiagnosisofTBbySputumMicroscopy

Apracticalguidetoassistlaboratorystaffinunderstandingtheimportantissuesinvolvedinconductingsputumsmearmicroscopy.

GLIMycobacteriologyLaboratoryManual

Detailedinformationonsamplepreparationandstaining,andsmearexamination(chapters7,8and9,respectively).

UNIONTrainingPackageonAcid-FastDirectSmearMicroscopy

Onlinetrainingpackageondirectsmearmicroscopy.

GLIStandardOperatingProceduresfortheTBLaboratory

TemplatesofSOPsfortheTBlaboratory,includingSOPtemplatesforsmearmicroscopy.

Biosafety

GLILaboratorySafetyHandbook

Includesinformationonbiosafetyspecificallyforsmearmicroscopy.

WHOTBLaboratoryBiosafetyManual

Includesinformationonbiosafetyspecificallyforsmearmicroscopy.

Other

TBfacts.org ThiswebsiteisausefulresourceprovidinginformationonTBingeneralandforTBlaboratorytestingspecifically,includingsmearmicroscopy.

19

Tuberculosis Technical Scorecard Building Quality-Assured Tuberculosis Testing and Management Capacity Utilizing SLIPTA Methodology Version 1.5 – July 2020

Information on completing the scorecard for TB culture for detection and identification of mycobacteria

PartA:GeneralInformation

Similartootherscorecards,partAofthisscorecardislimitedtoaddingdetailsaboutthisassessment(incl.nameandaffiliationoftheassessorandthelaboratorybeingassessed,andinformationaboutthepreviousassessment,ifany).

PartB:Technicalinformation

PartBstartswithatabletocollectinformationonthenumberofsolidandliquidculturetestsperformedinthelastyear,stratifiedbyoutcome.Itisrecommendedtoaskthelaboratorytocompletethistableinadvanceandverifytheinformationduringtheassessment,astherewillnotbesufficienttimeavailableduringtheassessmentforcompletionofthistable.

Theremainderofthisscorecardcontainsquestionsrelatedto:

• Section1:Documents&Records Containingquestionsaboutdocumentationofculture-specificprocedures.

• Section4:ClientManagement&CustomerService Containingaquestionrelatedtoprovisionofinformationandinstructionstoclientsoninterpretationofcultureresults.

• Section7:Purchasing&Inventory Containingaquestiononstorageofreagentsneededforsolidandliquidcultureandidentificationtests.

• Section8:ProcessControl ThissectionismostelaborateandinvestigatestechnicaldetailsforcorrectexecutionofTBculture.Thesectionisdividedintothefollowingsegments:qualitycontrol,decontamination,liquidcultureprocedure,solidcultureprocedure,andMTBidentificationprocedure.

• Section11: Containsaquestionrelatedtoculture-specificqualityindicators.

Mostquestionsareself-explicatoryandassessorscomplyingwiththeassessorprofiledescribedinsection3.4shouldbeabletoanswerthem.Below,severalusefulresourcesarelistedthatprovideessential(technical)informationabouttheTBcultureprocedures.

20

Resource Description

Culture procedures

GLIMycobacteriologyLaboratoryManual

Providesdetailedinformationonliquidandsolidcultureprocedures(chapters10and11,respectively).

GLI Training Package on CultureinSolidandLiquidMedia

Zippedfile(311MB)withtrainingmaterials.

GLIStandardOperatingProceduresfortheTBLaboratory

TemplatesofSOPsfortheTBlaboratory,includingSOPtemplatesforTBculture.

TBfacts.org InformationonTBculture.

Biosafety

GLILaboratorySafetyHandbook

IncludesinformationonbiosafetyspecificallyforTBculture.

WHOTBLaboratoryBiosafetyManual

IncludesinformationonbiosafetyspecificallyforTBculture.

21

Tuberculosis Technical Scorecard Building Quality-Assured Tuberculosis Testing and Management Capacity Utilizing SLIPTA Methodology Version 1.5 – July 2020

Information on completing the scorecard for Phenotypic Drug Susceptibility Testing (DST)

PartA:GeneralInformation

Similartootherscorecards,partAofthisscorecardislimitedtoaddingdetailsaboutthisassessment(incl.nameandaffiliationoftheassessorandthelaboratorybeingassessed,andinformationaboutthepreviousassessment,ifany).

PartB:Technicalinformation

PartBofthisscorecardstartswiththecollectionofquantitativedataonthenumberoftestsperformedlastyear,stratifiedbyoutcome.Itisrecommendedtoaskthelaboratorytocompletethistableinadvanceandverifytheinformationduringtheassessment,astherewillbenotbesufficienttimeavailableduringtheassessmentforcompletionofthistable.

Theremainderofthisscorecardcontainsquestionsrelatedto:

• Section1:Documents&Records ContainingquestionsaboutdocumentationofDST-specificprocedures.

• Section4:ClientManagement&CustomerService ContainingonequestionaskingaboutprovisionofinformationoncorrectinterpretationofDSTresultstolaboratoryclients.

• Section7:Purchasing&Inventory ContainingaquestiononstorageofantibioticsandmedianeededforDST.

• Section8:ProcessControl ThissectionismostelaborateandinvestigatestechnicaldetailsforcorrectexecutionofDST,includingqualitycontrol.

• Section11: ContainsaquestionrelatedtoDST-specificqualityindicators.

Mostquestionsareself-explicatoryandassessorscomplyingwiththeassessorprofiledescribedinsection3.4shouldbeabletoanswerthem.Below,severalusefulresourcesarelistedthatprovideessential(technical)informationaboutthephenotypicDSTprocedure.

22

Resource Description

DST procedures

WHOTechnicalmanualfordrugsusceptibilitytestingofmedicinesusedinthetreatmentoftuberculosis

ThistechnicalmanualfocusesontheavailableDSTmethodsforbothfirst-andsecond-lineanti-TBagents.Culture-basedphenotypicDSTmethodsforcertainanti-TBmedicinesarereliableandreproducible,butthesemethodsaretime-consuming,requiresophisticatedlaboratoryinfrastructure,qualifiedstaffandstrictqualitycontrol.OnlyindirectDSTproceduresforanti-TBmedicinesareincludedinthisdocument.ThemethodsdescribedareLJ,7H10and7H11agarandMGIT.

GLIMycobacteriologyLaboratoryManual

ProvidesdetailedinformationonDSTusingMGIT(chapter12).

GLITrainingPackageonDSTbyPhenotypicandMolecularMethods

Zippedfile(34MB)withtrainingmaterialsonDST.

TBCAREICompleteCultureandDSTPackage

Thispackage(140MB)containsstandardizedtrainingmaterialsoncultureandDSTtechniques.

GLIStandardOperatingProceduresfortheTBLaboratory

TemplatesofSOPsfortheTBlaboratory,includingSOPtemplatesforTBcultureandDST.

TB-CAREIStandardOperatingProceduresforCultureDSTandMolecularResistance Testing

ThispackageoffilescontainsnewSOPtemplatesonGeneXpert,MGIT960,DSTSolidandLPA.

TBfacts.org InformationonTBDST.

Biosafety

GLILaboratorySafetyHandbook

IncludesinformationonbiosafetyspecificallyforTBcultureandDST.

WHOTBLaboratoryBiosafetyManual

IncludesinformationonbiosafetyspecificallyforTBcultureandDST.

23

Tuberculosis Technical Scorecard Building Quality-Assured Tuberculosis Testing and Management Capacity Utilizing SLIPTA Methodology Version 1.5 – July 2020

Information on completing the Xpert MTB/RIF Scorecard

PartA:GeneralInformation

Similartootherscorecards,partAofthisscorecardislimitedtoaddingdetailsaboutthisassessment(incl.nameandaffiliationoftheassessorandthelaboratorybeingassessed,andinformationaboutthepreviousassessment,ifany).

PartB:Technicalinformation

PartBoftheXpertMTB/RIFScorecard(includingXpertMTB/RIFUltra)startswiththecollectionofquantitativedataonthenumberoftestsperformedlastyear,stratifiedbyoutcome.TheScoreTB-PackageadherestotheXpertreportingsystemrecommendedbyWHO6 and updated by GLI7. It is recommended toaskthelaboratorytocompletethistableinadvanceandverifytheinformationduringtheassessment,astherewillbenotbesufficienttimeavailableduringtheassessmentforcompletionofthistable.AnadditionalquestionisincludedtocollectinformationabouttheGeneXpertequipmentavailability,functionality,andmaintenance. Theremainderofthisscorecardcontainsquestionsrelatedto:

• Section1:Documents&Records ContainingquestionsaboutdocumentationofGeneXpert-specificprocedures.

• Section4:ClientManagement&CustomerService ContainingonequestionaskingaboutprovisionofinformationoncorrectinterpretationofGeneXpertresultstolaboratoryclients.

• Section7:Purchasing&Inventory ContainingaquestiononstorageofGeneXpertcartridges.

• Section8:ProcessControl ContainingquestionsontechnicalaspectsofGeneXperttesting,includingqualitycontrol.

• Section11: ContainsaquestionrelatedtoGeneXpert-specificqualityindicators.

Mostquestionsareself-explicatoryandassessorscomplyingwiththeassessorprofiledescribedinsection3.4shouldbeabletoanswerthem.Below,severalusefulresourcesarelistedthatprovideessential(technical)informationaboutGeneXpertMTB/RIFandMTB/RIFUltratesting.

6WHODefinitionsandReportingFrameworkforTuberculosis–2013revision:https://www.who.int/tb/publications/definitions/en/7GLIPlanningforcountrytransitiontoXpertMTB/RIFUltraCartridges:http://www.stoptb.org/wg/gli/assets/documents/gli_ultra.pdf

24

Resource Description

GeneXpert procedure

MovieonGeneXperttestingprocedure

TrainingvideoonconductingtheGeneXpertMTB/RIFtest.

GLITrainingPackageonDSTbyPhenotypicandMolecularMethods

Zippedfile(34MB)withtrainingmaterialsonDST.

ImplementingaQualityAssuranceSystemforXpertMTB/RIFTesting

Thispracticalguide,andaccompanyingshortguide,provideusefulinformationandtoolstoestablishingandimplementingaqualityassurance(QA)systemfortheXpertMTB/RIFtestacrossthediagnosticnetwork.

GeneXpertTrainingMaterialswithGuides(2015)

ThisisafulltrainingpackagewithguidestosupporttheuseofXpertMTB/RIF(84Mb).

StandardOperatingProceduresforCultureDSTandMolecularResistanceTesting

Thiszippedpackageoffiles(1.8MB)containsnewstandardoperatingproceduresonGeneXpert,MGIT960,DSTSolidandLPA.

TBfacts.org InformationontheGeneXpertforTBtesting.

TBonline.info InformationontheGeneXpertforTBtesting.

Biosafety

GLILaboratorySafetyHandbook

IncludesinformationonbiosafetyspecificallyforGeneXpert.

WHOTBLaboratoryBiosafetyManual

IncludesinformationonbiosafetyspecificallyforGeneXpert.

Other

GLIPlanningforcountrytransitiontoXpertMTB/RIFUltraCartridges

ThisguideprovidespracticalguidancetodevelopanactionableimplementationplantosmoothlytransitiontouseofXpertMTB/RIFUltracartridges,ensuringuninterruptedserviceandavoidingcartridgewastage.

25

Tuberculosis Technical Scorecard Building Quality-Assured Tuberculosis Testing and Management Capacity Utilizing SLIPTA Methodology Version 1.5 – July 2020

Information on completing the Loop-Mediated Isothermal Amplification (TB-LAMP) scorecard

PartA:GeneralInformation

Similartootherscorecards,partAofthisscorecardislimitedtoaddingdetailsaboutthisassessment(incl.nameandaffiliationoftheassessorandthelaboratorybeingassessed,andinformationaboutthepreviousassessment,ifany).

PartB:Technicalinformation

PartBoftheTB-LAMPscorecardstartswiththecollectionofquantitativedataonthenumberoftestsperformedlastyear,stratifiedbyoutcome.Itisrecommendedtoaskthelaboratorytocompletethistableinadvanceandverifytheinformationduringtheassessment,astherewillbenotbesufficienttimeavailableduringtheassessmentforcompletionofthistable.AnadditionalquestionisincludedtocollectinformationabouttheTB-LAMPequipmentavailability,functionality,andmaintenance. Theremainderofthisscorecardcontainsquestionsrelatedto:

• Section1:Documents&Records ContainingquestionsaboutdocumentationofTB-LAMP-specificprocedures.

• Section4:ClientManagement&CustomerService ContainingonequestionaskingaboutprovisionofinformationoncorrectinterpretationofTB-LAMPresultstolaboratoryclients.

• Section7:Purchasing&Inventory ContainingaquestiononstorageofTB-LAMPreagents.

• Section8:ProcessControl ContainingquestionsontechnicalaspectsofTB-LAMPtesting,includingqualitycontrol,DNAextractionandMTBCdetection.

• Section11:Occurrence/IncidenceManagement&ProcessImprovement ContainsaquestionrelatedtoTB-LAMP-specificqualityindicators.

Mostquestionsareself-explicatoryandassessorscomplyingwiththeassessorprofiledescribedinsection3.4shouldbeabletoanswerthem.Below,severalusefulresourcesarelistedthatprovideessential(technical)informationaboutTB-LAMPtesting.

26

Resource Description

TB-LAMP procedure

MovieonTB_LAMP Thisshort,animatedvideoshowsthebackground,themostimportantstepsaswellastheadvantagesoftheTB-LAMP.

LAMP-tutorial Shorttutorial(movie)ontheLAMPprinciple.

WHOFactsheetonTB-LAMP ShortdescriptionoftheTB-LAMPassayandWHOrecommendations.

TB-LAMPflyer InformationontheTB-LAMPassayprovidedbyitsmanufacturer.

GLITB-LAMPinformationnote

GLIPracticalconsiderationontheimplementationofTB-LAMP.

Other

WHOPolicyguidanceonTB-LAMP

PolicyguidanceontheuseofTB-LAMPforthediagnosisofpulmonaryTB.

27

Tuberculosis Technical Scorecard Building Quality-Assured Tuberculosis Testing and Management Capacity Utilizing SLIPTA Methodology Version 1.5 – July 2020

Information on completing the Lateral Flow Urine Lipoarabinomannan Assay (LF-LAM) scorecard

PartA:GeneralInformation

Similartootherscorecards,partAofthisscorecardislimitedtoaddingdetailsaboutthisassessment(incl.nameandaffiliationoftheassessorandthelaboratorybeingassessed,andinformationaboutthepreviousassessment,ifany).

PartB:Technicalinformation

PartBoftheLF-LAMscorecardstartswiththecollectionofquantitativedataonthenumberoftestsperformedlastyear,stratifiedbyoutcome.Itisrecommendedtoaskthelaboratorytocompletethistableinadvanceandverifytheinformationduringtheassessment,astherewillbenotbesufficienttimeavailableduringtheassessmentforcompletionofthistable.

Theremainderofthisscorecardcontainsquestionsrelatedto:

• Section1:Documents&Records ContainingquestionsaboutdocumentationofLF-LAM-specificprocedures.

• Section4:ClientManagement&CustomerService ContainingonequestionaskingaboutprovisionofinformationoncorrectinterpretationofLF-LAMresultstolaboratoryclients.

• Section7:Purchasing&Inventory ContainingaquestiononstorageofLF-LAMtests.

• Section8:ProcessControl ContainingquestionsontechnicalaspectsofLF-LAMtesting,includingqualitycontrol.

• Section11:Occurrence/IncidenceManagement&ProcessImprovement ContainsaquestionrelatedtoLF-LAM-specificqualityindicators.

Mostquestionsareself-explicatoryandassessorscomplyingwiththeassessorprofiledescribedinsection3.4shouldbeabletoanswerthem.Below,severalusefulresourcesarelistedthatprovideessential(technical)informationaboutLF-LAMtesting.

Resource Description

LF-LAM procedure

MovieonLF-LAM AshortmovieonhowtodotheFujifilmSILVAMPTBLAMtest.

GLILF-LAMinformationnote GLIPracticalinformationontheLF-LAMtest.

Other

WHOPolicyupdateonLF-LAM

Background,justificationandobjectivesfortherevisionofWHOpolicyonLF-LAM.

28

Information on completing the Line Probe Assay (LPA) scorecard

PartA:GeneralInformation

Similartootherscorecards,partAofthisscorecardislimitedtoaddingdetailsaboutthisassessment(incl.nameandaffiliationoftheassessorandthelaboratorybeingassessed,andinformationaboutthepreviousassessment,ifany).

PartB:Technicalinformation

PartBoftheLPAscorecardstartswiththecollectionofquantitativedataonthenumberoftests(categorizedbyMTBDRplusandMTBDRsl,andCM)performedlastyear,stratifiedbyoutcome.Itisrecommendedtoaskthelaboratorytocompletethistableinadvanceandverifytheinformationduringtheassessment,astherewillbenotbesufficienttimeavailableduringtheassessmentforcompletionofthistable.AnadditionalquestionisincludedtocollectinformationabouttheLPAequipmentavailability,functionality,andmaintenance. Theremainderofthisscorecardcontainsquestionsrelatedto:

• Section1:Documents&Records ContainingquestionsaboutdocumentationofLPA-specificprocedures.

• Section4:ClientManagement&CustomerService ContainingonequestionaskingaboutprovisionofinformationoncorrectinterpretationofLPAresultstolaboratoryclients.

• Section7:Purchasing&Inventory ContainingaquestiononstorageofLPAtestreagents.

• Section8:ProcessControl ContainingquestionsontechnicalaspectsofLPAtesting,includingqualitycontrol,extraction,amplificationanddetection.

• Section11:Occurrence/IncidenceManagement&ProcessImprovement ContainsaquestionrelatedtoLPA-specificqualityindicators

Mostquestionsareself-explicatoryandassessorscomplyingwiththeassessorprofiledescribedinsection3.4shouldbeabletoanswerthem.Below,severalusefulresourcesarelistedthatprovideessential(technical)informationaboutLPAtesting.

29

Tuberculosis Technical Scorecard Building Quality-Assured Tuberculosis Testing and Management Capacity Utilizing SLIPTA Methodology Version 1.5 – July 2020

Resource Description

LPA procedure

MovieonLPA DemonstrationofLPA(directdetectionofMTBandresistancetoisoniazidandrifampicin)insputum.

GLI guide on LPA interpretation and reporting

Interpretationandreportingguideforlaboratorystaffandclinicians.

TBfacts.org InformationontheLPAforTBtesting.

StandardOperatingProceduresforCultureDSTandMolecularResistanceTesting

Thiszippedpackageoffiles(1.8MB)containsnewSOPsonGeneXpert,MGIT960,DSTSolidandLPA.

GLITrainingPackageonDSTbyPhenotypicandMolecularMethods

Zippedfile(34MB)withtrainingmaterialsonDST.

Other

GLILaboratorySafetyHandbook

IncludesinformationonbiosafetyspecificallyforLPA.

Other

WHOPolicyupdateonLPA Policyupdateontheuseofmolecularlineprobeassaysforthedetectionofresistancetoisoniazidandrifampicin.

WHOPolicyupdateonLPAforsecondlineanti-TBdrugs

Policyupdateontheuseofmolecularlineprobeassaysforthedetectionofresistancetosecondlineanti-TBdrugs.

30

Information on completing the Truenat scorecard

PartA:GeneralInformation

Similartootherscorecards,partAofthisscorecardislimitedtoaddingdetailsaboutthisassessment(incl.nameandaffiliationoftheassessorandthelaboratorybeingassessed,andinformationaboutthepreviousassessment,ifany).

PartB:Technicalinformation

PartBoftheTruenatscorecardstartswiththecollectionofquantitativedataonthenumberoftestsperformedlastyear,stratifiedbyoutcome.Itisrecommendedtoaskthelaboratorytocompletethistableinadvanceandverifytheinformationduringtheassessment,astherewillbenotbesufficienttimeavailableduringtheassessmentforcompletionofthistable.AnadditionalquestionisincludedtocollectinformationabouttheTruenatequipmentavailability,functionality,andmaintenance. Theremainderofthisscorecardcontainsquestionsrelatedto:

• Section1:Documents&Records ContainingquestionsaboutdocumentationofTruenat-specificprocedures.

• Section4:ClientManagement&CustomerService ContainingonequestionaskingaboutprovisionofinformationoncorrectinterpretationofTruenatresultstolaboratoryclients.

• Section7:Purchasing&Inventory ContainingaquestiononstorageofTruenatreagents.

• Section8:ProcessControl ContainingquestionsontechnicalaspectsofTruenattesting,includingqualitycontrol.

• Section11:Occurrence/IncidenceManagement&ProcessImprovement ContainsaquestionrelatedtoTruenat-specificqualityindicators.

Mostquestionsareself-explicatoryandassessorscomplyingwiththeassessorprofiledescribedinsection3.4shouldbeabletoanswerthem.Below,severalusefulresourcesarelistedthatprovideessential(technical)informationaboutTruenattesting.

Resource Description

Truenat procedure

AnnouncementofWHOensorsementoftheTruenatassay

AnnouncementthatWHOhasendorsedtheTruenatassayforinitialdiagnosisofTBanddetectionofrifampicinresistance.

WHORapidCommunication:Molecularassaysasinitialtestsforthediagnosisoftuberculosisandrifampicinresistance

ThisdocumentaimstoinformnationalTBprogrammesandotherstakeholdersaboutthekeyimplicationsofthelatestevidenceontheuseofspecificmolecularassays,includingTruenat,asinitialdiagnostictestsofpulmonaryandextrapulmonaryTBandRR-TB,inadultsandchildren.

StopTB Partnership PracticalconsiderationsforimplementationofTruenat

ProvidespracticalconsiderationsforimplementationofTruenat,includingthetestprocedureandoperationalconsiderations.

TBfacts.org InformationontheTruenatassayforTBtesting.

31

Tuberculosis Technical Scorecard Building Quality-Assured Tuberculosis Testing and Management Capacity Utilizing SLIPTA Methodology Version 1.5 – July 2020

3.5 Reporting the assessment

Duringtheassessment:

1. FillintheGeneralProcedures-scorecardandthetest-specificscorecardsforallTBtestsperformedinthelaboratory.Dothiseitherusingthepaper-basedversionorinsertanswersandfindingsdirectlyintothee-tool(exceptwhenobservingTBtestingintheBSL3facilitywheretheuseofelectronicdevicesshouldbeavoidedforsafetyreasons,seesection3.4.1).

2. Optional:fillintheSLIPTAchecklist

Attheendoftheassessment,theassessormust: 3. Transcribeallscoresfromthepaper-basedversionsintothee-tool(ifapplicable).4. Thee-toolwillautomaticallycalculatethescoreandthenumberofstarsforeachoftheTBLabQualityScorecards(see“TBsummaryreport”worksheet). IftheSLIPTAchecklisthasalsobeencompletedthee-toolwillautomaticallycalculatetheSLIPTAscore,incorporatingthescoresontheTBLabQualityScorecards. NOTE:Calculatingthescorebyhandisextremelycomplexduetothepossibilityofnotapplicable-answersthatinfluencethetotalnumberofpointsthatcanbescored(seesection3.3.2).Calculatingthescorebyhandisthuspronetoerrors.Wethereforestronglyrecommendusingthee-tooltocalculatethescore.Anotheradvantageofusingthee-toolisthatitdirectlyvisualizesthescoringandtheprogresssincethepreviousassessment,ifapplicable.

5. Identifyrecommendationsforimprovement(forquestionswith“No”and“Partial”answers),andreportthesetothelaboratoryduringthemeetingwiththelaboratorymanagement(point6)andinthefinalreport(point7).

6. Wherepossible,theassessorshouldsupporttheirfindingswithtoolsandguidancematerialsasreferredinsection3.3.3tohelpthelaboratoryaddresstheareasforimprovement.Assessorsareresponsibleforensuringthattheresourcessuppliedtothelaboratoryaremostcurrent. Meetwiththelaboratorystaffandmanagementandcommunicatetheoverallfindingsoftheassessment.TheassessorshouldusetheformatsuggestedintheSLIPTAchecklist(Summary).i.e.reportnotedcommendations,notedchallengesandrecommendations.Wherepossible,theassessorshouldsupportthecommendations&challengeswithexamplesfromtheassessment.TheassessorcanalsopresentthenumberofstarsscoredontheTBLabQualityScorecardsandtheSLIPTAchecklist,ifapplicable(seepoint4).

Aftertheassessment:

7. Withintwoweeksaftertheassessment,theassessormustsubmitafinalreporttothelaboratory.ThereportshouldincludeacopyofthecompletedTBLabQualityScorecards(andSLIPTAchecklistifapplicable)aswellastheobservedchallengesandrecommendations.

Thelistofrecommendationsforimprovementshouldbecommunicatedintheformofnonconformitiesandmustbegradedasmajororminor:

• Majornonconformitiesarethosenon-conformitiesthatdirectlyinfluencethequalityoftheworkperformedandthereforerequireurgentaction.

• Minornonconformitiesarethosethatmayindirectlycompromisequalityoftheworkperformedandshouldbeaddressedaftermajornonconformitieshavebeenresolved.

Furthertothisitisadvisabletoprioritizetherecommendationstoassistthelaboratorywithimplementing/improvingitsQMSinalogicalandrationalway.

Thelaboratoryisresponsibleforaddressingthenonconformitiesthroughitsowncorrectiveactionsystem.Supporttothelaboratorytoaddressnonconformitiesisbeyondthescopeoftheassessmentbutcanbeprovidedintheformofamentorprogram.

32

Tuberculosis Technical Scorecard Building Quality-Assured Tuberculosis Testing and Management Capacity Utilizing SLIPTA Methodology Version 1.5 – July 2020

References

1. NkengasongJN,Mbopi-KeouFX,PeelingRW,YaoK,ZehCE,SchneidmanM,etal.LaboratorymedicineinAfricasince2008:then,now,andthefuture.LancetInfectDis.2018;3099(18).

2. NkengasongJN.Strengtheninglaboratoryservicesandsystemsinresource-poorcountries.AmJClinPathol.2009Jun;131(6):774.

3. MartinR,BarnhartS.GlobalLaboratorySystemsDevelopment:NeedsandApproaches.InfectDisClinNA.2011;25(3):677–91.

4. NkengasongJN,NsubugaP,NwanyanwuO,Gershy-DametG-M,RoscignoG,BulterysM,etal.Laboratorysystemsandservicesarecriticalinglobalhealth:timetoendtheneglect?AmJClinPathol.2010Sep;134(3):368–73.

5. OkekeIN.DiagnosticinsufficiencyinAfrica.ClinInfectDis.2006May;42(10):1501–3.6. BatesI,MaitlandK.Arelaboratoryservicescomingofageinsub-SaharanAfrica?ClinInfectDis.2006Feb;42(3):383–4.

7. MuulaAS,MasekoFC.MedicallaboratoryservicesinAfricadeservemore.ClinInfectDis.2006May;42(10):1503.

8. AlbertH,deDieuIragenaJ,KaoK,ErniD,MekonenT,OnyebujohPC.ImplementationofqualitymanagementsystemsandprogresstowardsaccreditationofNationalTuberculosisReferenceLaboratoriesinAfrica.AfrJLabMed.2017;6(2):a490.

9. JointWHO–CDCConferenceonHealthLaboratoryQualitySystems.InLyon:WorldHealthOrganisation;2008.

10.PeterTF,RotzPD,BlairDH,KhineAA,FreemanRR,MurtaghMM.Impactoflaboratoryaccreditationonpatientcareandthehealthsystem.AmJClinPathol.2010;134(4):550–5.

11. BarbeB,YansouniCP,AffolabiD,JacobsJ.Implementationofqualitymanagementforclinicalbacteriologyinlow-resourcesettings.ClinMicrobiolInfect.2017Jul;23(7):426–33.

12. ISO15189:2012Medicallaboratories-Requirementsforqualityandcompetence.Geneva:InternationalOrganizationforStandardization;2012.

13. ISO9000:2005Qualitymanagementsystems-Fundamentalsandvocabulary.Geneva:InternationalOrganizationforStandardization;2005.

14. JangMA,YoonYA,SongJ,KimJH,MinWK,LeeJS,etal.EffectofAccreditationonAccuracyofDiagnosticTestsinMedicalLaboratories.AnnLabMed.2017May;37(3):213–22.

15. YaoK,McKinneyB,MurphyA,RotzP,WafulaW,SendagireH,etal.Improvingqualitymanagementsystemsoflaboratoriesindevelopingcountries:aninnovativetrainingapproachtoacceleratelaboratoryaccreditation.AmJClinPathol.2010Sep;134(3):401–9.

16.MarutaT,MotebangD,MathaboL,RotzPJ,WanyoikeJ,PeterT.ImpactofmentorshiponWHO-AFROStrengtheningLaboratoryQualityImprovementProcessTowardsAccreditation(SLIPTA).AfrJLabMed.2012;1(1):a6.

17. Gershy-DametG-M,RotzP,CrossD,BelabbesEH,ChamF,NdihokubwayoJ-B,etal.TheWorldHealthOrganizationAfricanregionlaboratoryaccreditationprocess:improvingthequalityoflaboratorysystemsintheAfricanregion.AmJClinPathol.2010Sep;134(3):393–400.

18. StepwiseLaboratoryQuailtyImprovementProcessTowardsAccreditation(SLIPTA)Checklist.Brazzaville:WorldHealthOrganizationRegionalOfficeforAfrica;2015.

19.AlbertH,TrollipA,ErniD,KaoK.Developingacustomisedapproachforstrengtheningtuberculosislaboratoryqualitymanagementsystemstowardaccreditation.AfrJLabMed.2017;6(2):a576.

Recommended